These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26722395)

  • 1. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
    Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
    Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
    Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
    Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
    Li Y; Li L; Brown TJ; Heldin P
    Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
    Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
    Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
    Udabage L; Brownlee GR; Nilsson SK; Brown TJ
    Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
    Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
    Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.
    Udabage L; Brownlee GR; Waltham M; Blick T; Walker EC; Heldin P; Nilsson SK; Thompson EW; Brown TJ
    Cancer Res; 2005 Jul; 65(14):6139-50. PubMed ID: 16024615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
    Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
    FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
    BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.
    Cook AC; Chambers AF; Turley EA; Tuck AB
    J Biol Chem; 2006 Aug; 281(34):24381-9. PubMed ID: 16807238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
    Simpson MA
    Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
    Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
    Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).
    Bernert B; Porsch H; Heldin P
    J Biol Chem; 2011 Dec; 286(49):42349-42359. PubMed ID: 22016393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.
    Sheng Y; Cao M; Liu Y; He Y; Zhang G; Du Y; Gao F; Yang C
    Mol Cell Biochem; 2021 Sep; 476(9):3383-3391. PubMed ID: 33954907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
    Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
    Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
    Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
    J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
    Guin S; Ru Y; Agarwal N; Lew CR; Owens C; Comi GP; Theodorescu D
    Clin Cancer Res; 2016 Mar; 22(5):1274-83. PubMed ID: 26490312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.